Phonak Sphere Infinio vs RxEars Rxi

The Phonak Sphere Infinio is a premium behind-the-ear prescription hearing aid released in 2024, priced at $4,898. In our lab testing, it earned an A grade with a SoundScore of 5.0/5, placing it at #2 among 39 prescription hearing aids tested—within the top 3% of its category. The standout performance comes in speech clarity. Speech in noise scores an excellent 4.7/5, a remarkable 2.59 points above the category average of 2.11/5. Speech in quiet also impresses at 4.5/5, sitting 1.07 points above average. For anyone who struggles to follow conversations in restaurants, gatherings, or busy environments, this device delivers measurably superior intelligibility compared to most alternatives we've tested. Music streaming quality is strong at 4.0/5, exceeding the category average by 1.24 points—a meaningful advantage for users who value audio fidelity when streaming from phones. However, own-voice comfort is mixed at 2.3/5, falling 0.40 points below the category average, which may affect how natural your own speech sounds. Feedback handling, while solid in absolute terms at 3.6/5, sits 1.12 points below the category average of 4.72/5. The Sphere Infinio is best suited for users prioritizing exceptional speech understanding, particularly in challenging noise environments, and who are willing to invest at the premium tier. Those especially sensitive to own-voice quality or requiring maximum feedback stability may want to compare alternatives like the similarly-priced Oticon Intent or the lower-priced Phonak Audéo EON Sphere.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it ranks #24 of 39 prescription hearing aids tested, placing it in the top 59% of its category. This device demonstrates notable strengths in speech understanding in quiet environments, scoring 4.3/5—a strong result that sits 0.89 points above the category average of 3.40/5. Feedback handling is excellent at 4.7/5, providing stable performance during movement without the whistling that can plague some hearing aids. Speech in noise performance is mixed at 2.1/5, essentially matching the category average. The RxEars Rxi has significant limitations to consider. Own-voice comfort scores low at 1.6/5, falling 1.10 points below the category average—users may notice their own voice sounds unnatural or boomy. Music streaming is not supported, scoring 0.0/5, which is 2.76 points below the category average. This device uses disposable batteries rather than rechargeables. The RxEars Rxi is best suited for users who prioritize discreet cosmetics and clear speech understanding in quieter settings, and who don't need music streaming capabilities. Those sensitive to own-voice quality or who frequently listen to streamed audio should explore alternatives.